Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis

被引：0
|
作者：
Gore, M. E.
Porta, C.
Oudard, S.
Bjarnason, G.
Castellano, D.
Szczylik, C.
Mainwaring, P. N.
Schoffski, P.
Rini, B. I.
Bukowski, R. M.
机构：
[1] Royal Marsden Hosp NHS Trust, London, England
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Mil Inst Med, Warsaw, Poland
[7] Mater Adult Hosp, South Brisbane, Australia
[8] Leuven Canc Inst, Leuven, Belgium
[9] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis
    Gore, M.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 299 - 299
  • [2] Safety and efficacy of sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of an Italian expanded-access program (EAP) with subpopulation analysis
    Stemberg, Cora N.
    Porta, Camillo
    Bracarda, Sergio
    Carteni, Giacomo
    Lo Re, Giovanni
    Ruggeri, Enzo M.
    Conte, Pierfranco
    Monfardini, Silvio
    Gasparini, Giampietro
    Ciuffreda, Libero
    Marini, Giovanni
    Bonetti, Andrea
    Heouaine, Abdhelhamid
    Bernardini, Ilaria
    Ravaioli, Alberto
    Labianca, Roberto
    JOURNAL OF UROLOGY, 2008, 179 (04): : 418 - 418
  • [3] Safety and efficacy of sunitinib in an expanded-access trial of metastatic renal cell carcinoma (MRCC): Updated results and subpopulation analysis
    Oudard, S.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 246 - 246
  • [4] Subpopulation analysis from an ongoing expanded-access trial of Sunitinib in metastatic renal cell carcinoma
    Eberhardt, W.
    Weigang-Koehler, K.
    Gruenwald, V.
    Fiedler, W.
    Steiner, T.
    Stoeckle, M.
    Bergmann, L.
    Casper, J.
    Wirth, M. P.
    Gore, M. E.
    ONKOLOGIE, 2008, 31 : 179 - 179
  • [5] SUNITINIB GLOBAL EXPANDED-ACCESS TRIAL IN METASTATIC RENAL CELL CARCINOMA (MRCC) - FINAL RESULTS
    Gore, M. E.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Crino, L.
    Kim, T. M.
    Fly, K.
    Szczylik, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 271 - 271
  • [6] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final US results
    Hutson, T. E.
    Dudek, A. Z.
    Fishman, M. N.
    Thompson, J. A.
    Agarwal, N.
    George, D. J.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Dreicer, R.
    BJU INTERNATIONAL, 2013, 112 : 4 - 5
  • [7] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final Italian results
    Sternberg, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Masini, C.
    Fly, K.
    Zhang, K.
    Hariharan, S.
    Capaccetti, B.
    Porta, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S644 - S644
  • [8] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain
    Castellano, D.
    Garcia del Muro, X.
    Climent, M. A.
    Maroto, P.
    Perez-Gracia, J. L.
    Lopez-Vivanco, G.
    Zhang, K.
    Fly, K.
    Hariharan, S.
    Anton-Aparicio, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S666 - S666
  • [9] Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC)
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Short- and long-term safety with sunitinib in an expanded access trial in metastatic renal cell carcinoma (mRCC)
    Porta, C.
    Szczylik, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345